Offer - Urjas Oil for just ₹ 1 X
Nebipil 5 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of High BP.
Medical history of the patient along with age and gender determines the dosage of Nebipil 5 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Nebipil 5 Tablet can also lead to other problems, which have been listed below. Such side effects of Nebipil 5 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Nebipil 5 Tablet's effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Nebipil 5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Nebipil 5 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) are examples of such conditions. Some other conditions that can be affected by Nebipil 5 Tablet are listed in the contraindications section below.
Additionally, Nebipil 5 Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Nebipil 5 Tablet is not safe while driving, and is is not addictive in nature.
Nebipil 5 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Nebipil 5 Tablet safe for pregnant women?
Nebipil should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Nebipil 5 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Nebipil. It should only be taken after medical advice.
What is the effect of Nebipil 5 Tablet on the Kidneys?
Nebipil rarely harms the kidneys.
What is the effect of Nebipil 5 Tablet on the Liver?
Nebipil may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Nebipil 5 Tablet on the Heart?
Nebipil may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Nebipil 5 Tablet unless your doctor advises you to do so -
Is this Nebipil 5 Tablet habit forming or addictive?
Nebipil 5 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Nebipil 5 Tablet can make you feel drowsy.
Is it safe?
Yes, but consume Nebipil 5 Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Nebipil 5 Tablet in mental disorders is not effective.
Interaction between Food and Nebipil 5 Tablet
When consumed with certain foods, Nebipil 5 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Nebipil 5 Tablet
Taking Nebipil 5 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897